CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions

Mark S Duxbury; Evan Matros; Thomas Clancy; Gerald Bailey; Michael Doff; Michael J Zinner; Stanley W Ashley; Anirban Maitra; Mark Redston; Edward E Whang

CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions

Mark S Duxbury, Evan Matros, Thomas Clancy, Gerald Bailey, Michael Doff, Michael J Zinner, Stanley W Ashley, Anirban Maitra, Mark Redston, Edward E Whang

Deanery of Clinical Sciences

Research output: Contribution to journal › Article › peer-review

Abstract

The purpose of this study was to test the hypothesis that CEACAM6 expression is an indicator of adverse pathologic features and clinical outcome in pancreatic adenocarcinoma.

Original language	English
Pages (from-to)	491-6
Number of pages	6
Journal	Annals of Surgery
Volume	241
Issue number	3
Publication status	Published - 2005

Fingerprint Dive into the research topics of 'CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions'. Together they form a unique fingerprint.

Cite this

@article{18f4f1960d7844fc8ffd62041eb08712,

title = "CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions",

abstract = "The purpose of this study was to test the hypothesis that CEACAM6 expression is an indicator of adverse pathologic features and clinical outcome in pancreatic adenocarcinoma.",

author = "Duxbury, {Mark S} and Evan Matros and Thomas Clancy and Gerald Bailey and Michael Doff and Zinner, {Michael J} and Ashley, {Stanley W} and Anirban Maitra and Mark Redston and Whang, {Edward E}",

year = "2005",

language = "English",

volume = "241",

pages = "491--6",

journal = "Annals of Surgery",

issn = "0003-4932",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions

AU - Duxbury, Mark S

AU - Matros, Evan

AU - Clancy, Thomas

AU - Bailey, Gerald

AU - Doff, Michael

AU - Zinner, Michael J

AU - Ashley, Stanley W

AU - Maitra, Anirban

AU - Redston, Mark

AU - Whang, Edward E

PY - 2005

Y1 - 2005

N2 - The purpose of this study was to test the hypothesis that CEACAM6 expression is an indicator of adverse pathologic features and clinical outcome in pancreatic adenocarcinoma.

AB - The purpose of this study was to test the hypothesis that CEACAM6 expression is an indicator of adverse pathologic features and clinical outcome in pancreatic adenocarcinoma.

M3 - Article

C2 - 15729073

VL - 241

SP - 491

EP - 496

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 3

ER -